Analysis of 54 clinically diagnosed primary patient samples published on the PedcBioPortal from the Pediatric Brain Tumor Atlas (PBTA) shows that CDKN2A rarely has structural variants in ATRT, with only 2% of samples having a deep deletion [4, 11, 20]. Here, CDKN2A is linked to brain neoplasm.